Works matching IS 15228517 AND DT 2023 AND VI 25 AND IP 8
Results: 19
Forthcoming Meetings.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 8, p. 1550, doi. 10.1093/neuonc/noad123
- Publication type:
- Article
Sabotaging the protein factory to overcome glioma stem cell resistance.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Reply to Di Nunno et al. concerning objective response rates targets for recurrent glioblastoma clinical trials: Toward surrogate endpoints for phase II trials in patients with recurrent glioblastoma.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 8, p. 1548, doi. 10.1093/neuonc/noad085
- By:
- Publication type:
- Article
Cerebrospinal fluid: The new frontier for methylome-based diagnostic classification of brain tumors.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 8, p. 1461, doi. 10.1093/neuonc/noad075
- By:
- Publication type:
- Article
Letter concerning "Objective response rate targets for recurrent glioblastoma clinical trials based on the historic association between ORR and median overall survival": Toward surrogate endpoints for phase II trials in patients with recurrent glioblastoma
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 8, p. 1546, doi. 10.1093/neuonc/noad071
- By:
- Publication type:
- Article
Primary papillary epithelial tumor of the sella and posterior pituitary tumor show similar (epi)genetic features and constitute a single neuro-oncological entity.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 8, p. 1487, doi. 10.1093/neuonc/noad067
- By:
- Publication type:
- Article
Multicenter, prospective, phase II study of maintenance bevacizumab for children and adults with NF2-related schwannomatosis and progressive vestibular schwannoma.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 8, p. 1498, doi. 10.1093/neuonc/noad066
- By:
- Publication type:
- Article
Mitotic index is (still) important for grading isocitrate dehydrogenase (IDH)-mutant astrocytoma.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 8, p. 1450, doi. 10.1093/neuonc/noad063
- By:
- Publication type:
- Article
Epidemiology, biology, and management of venous thromboembolism in gliomas: An interdisciplinary review.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 8, p. 1381, doi. 10.1093/neuonc/noad059
- By:
- Publication type:
- Article
Cognitive outcomes after multimodal treatment in adult glioma patients: A meta-analysis.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 8, p. 1395, doi. 10.1093/neuonc/noad045
- By:
- Publication type:
- Article
Molecular changes underlying decay of sensory responses and enhanced seizure propensity in peritumoral neurons.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 8, p. 1463, doi. 10.1093/neuonc/noad035
- By:
- Publication type:
- Article
Clinical, histological, and molecular features of gliomas in adults with neurofibromatosis type 1.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 8, p. 1474, doi. 10.1093/neuonc/noad033
- By:
- Publication type:
- Article
Efficient detection and monitoring of pediatric brain malignancies with liquid biopsy based on patient-specific somatic mutation screening.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 8, p. 1507, doi. 10.1093/neuonc/noad032
- By:
- Publication type:
- Article
Nivolumab with or without ipilimumab in pediatric patients with high-grade CNS malignancies: Safety, efficacy, biomarker, and pharmacokinetics—CheckMate 908.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 8, p. 1530, doi. 10.1093/neuonc/noad031
- By:
- Publication type:
- Article
Risk prediction in early childhood sonic hedgehog medulloblastoma treated with radiation-avoiding chemotherapy: Evidence for more than 2 subgroups.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 8, p. 1518, doi. 10.1093/neuonc/noad027
- By:
- Publication type:
- Article
Novel murine glioblastoma models that reflect the immunotherapy resistance profile of a human disease.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 8, p. 1415, doi. 10.1093/neuonc/noad025
- By:
- Publication type:
- Article
Mitotic count is prognostic in IDH mutant astrocytoma without homozygous deletion of CDKN2A/B. Results of consensus panel review of EORTC trial 26053 (CATNON) and EORTC trial 22033-26033.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 8, p. 1443, doi. 10.1093/neuonc/noac282
- By:
- Publication type:
- Article
Novel INHAT repressor drives glioblastoma growth by promoting ribosomal DNA transcription in glioma stem cells.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 8, p. 1428, doi. 10.1093/neuonc/noac272
- By:
- Publication type:
- Article
Cerebrospinal fluid methylome-based liquid biopsies for accurate malignant brain neoplasm classification.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 8, p. 1452, doi. 10.1093/neuonc/noac264
- By:
- Publication type:
- Article